It's an absolute disgrace that GE seems to think that rats are more important than HUMAN embryos. To add insult to injury, they are destroying life for research that has shown NO results.
GE Healthcare has formed a biotech partnership to develop products based on human embryonic stem cells in hopes that their use will replace lab rats in drug development and toxic drug tests.
The British-based medical research subsidiary of General Electric, GE Healthcare on June 30 announced a multi-year alliance with Geron Corporation to have Geron provide GE scientists with an undisclosed amount of human embryonic stem cells.
According to CNSNews.com, GE Healthcare has said it hopes testing which uses human embryonic cells will spare lab rats from potentially toxic drug evaluations.
"This could replace, to a large extent, animal trials," said Konstantin Fiedler, general manager of cell technologies at GE Healthcare. “Once you have human cells and you can get them in a standardized way, like you get right now, your lab rats in a standardized way, you can actually do those experiments on those cells.”
A Geron/GE news release said that cells derived from human embryos have “similar attributes to their counterparts in the body” and can be used to predict “many pharmacological characteristics of a drug candidate.”